Stocks

The table gives an overview of all stocks, alphabetically sorted.

Show advanced options
 K & S AG SDF Apr 25, 2025 14.04 +3.39   
 K & S AG SDF1 Apr 25, 2025 6.75 +3.05   
 K-BRO LINEN INC. 74R Apr 25, 2025 22.60 -0.88   
 K-Fast Holding B 6D90 Apr 25, 2025 1.04 +0.97   
 K. WAH INTL KW2 Apr 25, 2025 0.18 +1.66   
 K2 Gold Corp 23K Apr 25, 2025 0.12 -12.68   
 K2A KNAUST+ANDERSSON B F70 Apr 25, 2025 0.58 +7.26   
 K9 Gold 5GP0 Apr 25, 2025 0.06 +6.03   
 K92 Mining Inc 92K Apr 25, 2025 8.04 -4.29   
 KA SHUI INTL MI8 Apr 25, 2025 0.01 +37.50   
 Kadant, Inc. KDA Apr 25, 2025 278.00 +2.96   
 Kaga Electronics Co. Ltd 9V2 Apr 25, 2025 15.40 +4.05   
 Kagome Co Ltd Ordinary Shares (Japan) 5EW Apr 25, 2025 17.50 -4.37   
 Kainos Group Plc 1KG Apr 25, 2025 8.10 -0.61   
 Kairos Minerals Limited YAJ Apr 25, 2025 0.01 +2.17   
 Kaiser Aluminum Corporation KLU1 Apr 25, 2025 54.00 +12.50   
 Kaiser Reef Limited 7YR Apr 25, 2025 0.09 -4.47   
 Kajima Corporation KAJ Apr 25, 2025 20.40 +6.25   
 KaKaKu.com, Inc KKC Apr 25, 2025 14.70 +2.08   
 Kala Pharmaceuticals 27F0 Apr 25, 2025 2.69 -10.21   
 Kalamazoo Resources Limited KR1 Apr 25, 2025 0.04 -0.50   
 Kalbe Farma Tbk LCLA Apr 25, 2025 0.06 +3.51   
 KALI METALS ORD.F.P. O.N. 6OB Apr 25, 2025 0.05 +33.33   
 Kalina Power LImited WHS Apr 25, 2025 0.00 0.00   
 KALMAR OYJ B XK2 Apr 25, 2025 27.08 +6.61   
 Kalo Gold Corp 0SX0 Apr 25, 2025 0.02 +20.59   
 Kalray SA 3FS Apr 25, 2025 0.56 +0.72   
 Kaltura Inc 73Q Apr 25, 2025 1.79 +2.87   
 KalVista Pharmaceuticals, Inc. 4XC1 Apr 25, 2025 11.00 +7.84   
 Kamux 4K8 Apr 25, 2025 2.31 +1.09   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.